FDA Approves BioForm’s Radiesse Dermal Filler For HIV, Cosmetic Indications

BioForm says it will likely go public within the next year following approval of its Radiesse dermal filler for the cosmetic treatment of nasolabial folds and facial wasting in patients with HIV

More from Archive

More from Medtech Insight